Longstanding problems demand new solutions and unlock newer revenue streams. As the technological landscape of proteomics matures and evolves, so does the business model of both incumbents and new entrants.
This is the second part of a larger series exploring the field of proteomics. In the first part, we covered the basics of proteomics: why we need to study it, where the challenges lie in the domain and what is expected to happen in the very near future. In the next chapters, we will be looking at some disruptive companies and their offerings. But before we get there, it is good to understand the revenue streams and business models in the proteomics space. Proteomics, by its nature, is a multilayered marketplace that enables multiple revenue streams. …
PROTEINS
Accurately identifying and quantifying proteins has been a long-standing technical challenge. Startups are tackling it with audacious approaches.
What is the proteome?
Just as the genome is the collection of all genes present in an organism, the “proteome” is the collection of all proteins therein. The human proteome, hence, is the complete set of proteins that can be found in the human body.
Why do we need to read it?
Remember the central dogma of biology: DNA → RNA → Proteins. DNA is transcribed into RNA which in turn is translated into proteins.
Reading our genes, through the much popular technology called DNA sequencing allows us to peek at the biological equivalent of the source code. We can think of it as the instruction set of what was supposed…
Abhijeet Patra
Investor-Entrepreneur-Scientist. I am interested in and deeply think about interdisciplinary technologies that seem like science fiction, but is just science.
